Advertisement
Letter to the Editor| Volume 68, e12-e14, October 2019

The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience

  • Massimo Radin
    Affiliations
    Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy

    School of Specialization of Clinical Pathology, Department of Clinical and Biological Sciences, University of Turin, Italy
    Search for articles by this author
  • Savino Sciascia
    Correspondence
    Corresponding author at: Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Piazza del Donatore di Sangue 3, 10154 Turin, Italy.
    Affiliations
    Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy

    Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy
    Search for articles by this author
  • Irene Cecchi
    Affiliations
    Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy

    School of Specialization of Clinical Pathology, Department of Clinical and Biological Sciences, University of Turin, Italy
    Search for articles by this author
  • Giulio Mengozzi
    Affiliations
    AOU Città della Salute e della Scienza, Turin, Italy
    Search for articles by this author
  • Dario Roccatello
    Affiliations
    Center of Research of Immunopathology and Rare Diseases, Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy

    Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy
    Search for articles by this author
Published:August 02, 2019DOI:https://doi.org/10.1016/j.ejim.2019.07.026
The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience
Previous ArticlePrevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients
Next ArticleListeria infection in patients using anti-TNFα treatment: Should there be preventive strategies?

      Highlights

      • •
        Especially at onset, the diagnosis of SLE can be challenging.
      • •
        In this real-world prospective study, patients later diagnosed with SLE had higher SLE-key scores.
      • •
        Multiparametric autoimmune diagnostics can allow to simultaneously test for a panel of antibodies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Bertolaccini M.L.
        • Sciascia S.
        • Radin M.
        • Roccatello D.
        • Sanna G.
        Recent advances in the management of systemic lupus erythematosus [version 1; referees: 2 approved].
        F1000Research. 2018; 7
        View in Article
        • Petri M.
        • Orbai A.-M.
        • Alarcón G.S.
        • Gordon C.
        • Merrill J.T.
        • Fortin P.R.
        • et al.
        Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus.
        Arthritis Rheum. 2012; 64 (Available from:): 2677-2686
        http://www.ncbi.nlm.nih.gov/pubmed/22553077
        Date accessed: January 2, 2019
        View in Article
        • Abeles A.M.
        • Gomez-Ramirez M.
        • Abeles M.
        • Honiden S.
        Antinuclear antibody testing: discordance between commercial laboratories.
        Clin Rheumatol. 2016; 35 (Available from:): 1713-1718
        http://www.ncbi.nlm.nih.gov/pubmed/27044430
        Date accessed: January 2, 2019
        View in Article
        • Pisetsky D.S.
        Anti-DNA antibodies — quintessential biomarkers of SLE.
        Nat Rev Rheumatol. 2015; 12 (Available from:): 102-110
        http://www.nature.com/doifinder/10.1038/nrrheum.2015.151
        Date accessed: August 11, 2016
        View in Article
        • Putterman C.
        • Wu A.
        • Reiner-Benaim A.
        • Batty D.S.
        • Sanz I.
        • Oates J.
        • et al.
        SLE-key® rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: developing the ImmunArray iCHIP®.
        J Immunol Methods. 2016; 429 (Available from:): 1-6
        http://www.ncbi.nlm.nih.gov/pubmed/26678162
        Date accessed: January 2, 2019
        View in Article
        • Fattal I.
        • Shental N.
        • Mevorach D.
        • Anaya J.-M.
        • Livneh A.
        • Langevitz P.
        • et al.
        An antibody profile of systemic lupus erythematosus detected by antigen microarray.
        Immunology. 2010; 130 (Available from:): 337-343
        http://www.ncbi.nlm.nih.gov/pubmed/20201986
        Date accessed: January 2, 2019
        View in Article
        • Shiboski C.H.
        • Shiboski S.C.
        • Seror R.
        • Criswell L.A.
        • Labetoulle M.
        • Lietman T.M.
        • et al.
        American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.
        Arthritis Rheumatol (Hoboken, NJ). 2016; 69 (2017. Available from): 35-45
        http://www.ncbi.nlm.nih.gov/pubmed/27785888
        Date accessed: January 2, 2019
        View in Article
        • Aletaha D.
        • Neogi T.
        • Silman A.J.
        • Funovits J.
        • Felson D.T.
        • Bingham C.O.
        • et al.
        2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative.
        Ann Rheum Dis. 2010; 69 (Available from:): 1580-1588
        http://www.ncbi.nlm.nih.gov/pubmed/20699241
        Date accessed: January 2, 2019
        View in Article
        • Mosca M.
        • Tani C.
        • Vagnani S.
        • Carli L.
        • Bombardieri S.
        The diagnosis and classification of undifferentiated connective tissue diseases.
        J Autoimmun. 2014; 48 (Available from:): 50-52
        http://www.ncbi.nlm.nih.gov/pubmed/24518855
        Date accessed: January 2, 2019
        View in Article
        • Radin M.
        • Cecchi I.
        • Roccatello D.
        • Meroni P.L.
        • Sciascia S.
        Prevalence and thrombotic risk assessment of anti-β2 glycoprotein I domain I antibodies: a systematic review.
        Semin Thromb Hemost. 2018; 44: 466-474
        View in Article

      Article info

      Publication history

      Published online: August 02, 2019
      Accepted: July 25, 2019
      Received in revised form: July 24, 2019
      Received: July 11, 2019

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2019.07.026

      Copyright

      © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX